NCT04088448View on ClinicalTrials.gov

The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Major Depressive Disorder
Interventions
DRUG

Placebo oral tablet

Fluoxetine 20 mg capsule plus Placebo tablet administered once daily after food

DRUG

Metformin

Fluoxetine 20 mg capsule plus Metformin 1000 mg extended release tablet administered once daily after food

Trial Locations (1)

Unknown

Faculty of Medicine, Tanta

All Listed Sponsors
lead

Sadat City University

OTHER

NCT04088448 - The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients | Biotech Hunter | Biotech Hunter